When the P-values of CHASM (Cancer-specific High-throughput Annotation of Somatic Mutations) and VEST (Variant Effect Scoring Tool) were both set at < 0.05, four genes with mutations were determined to be significant: SLC39A7, GPR19, ZNF717, and TP53 (Table 2). This evidence concerns the gene SLC39A7 and cancer.